m+Medelevator.RU
← Поиск публикаций
Clinical and translational medicine · 2026

Activated immune cells present a lung interstitial-to-airway/alveolar cross-compartment sharing pattern in severe pneumonia.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhao Yuean, Gong Linjing, Yu He, Zhang Sifan, Yang Guanglei, Wang Chaoyang, Wang Weiya, Cai Xuyu, Wang Ye

Аннотация

BACKGROUND: Immune cells play a pivotal role in the pathogenesis of severe pneumonia. However, the global atlas of immune cells under this condition is not fully understood.

METHODS: We conducted single-cell analyses of 275 411 cells isolated from matched lung tissue, bronchoalveolar lavage fluid, and peripheral blood from 12 patients with severe pneumonia and 5 donors, in order to identify the cross-compartment sharing pattern of activated immune cells and the roles they play in severe pneumonia.

RESULTS: Our observations revealed that activated immune cells distributed across lung interstitia and airways (alveoli; Pattern 1a), including activated tissue-resident memory-like CD8+ T cells (T8_rms), plasma cells and plasmablasts, and the pro-inflammatory macrophages. The activated T8_rms were derived from circulating CX3CR1+ CD8+ T cells, which upregulated ITGAE and CXCR3 during lung infiltration. Similarly, plasma cells and plasmablasts expressing ITGAE and CXCR3 also indicated the potential lung interstitial-to-airway/alveolar sharing pattern. The pro-inflammatory macrophages interacted with T8_rms and plasma cells via the CXCL10-CXCR3 axis.

CONCLUSIONS: The lung interstitial-to-airway/alveolar cross-compartment sharing pattern of activated immune cells (Pattern 1a) provide a robust working hypothesis for clinical and translational research for severe pneumonia.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты